{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:22:39Z","timestamp":1792718559909,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.vaccine.2023.07.063","type":"journal-article","created":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T19:22:10Z","timestamp":1691263330000},"page":"5722-5729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vaccine safety surveillance in Kenya using GAIA standards: A feasibility assessment of existing national and subnational research and program systems"],"prefix":"10.1016","volume":"41","author":[{"given":"P.","family":"Izulla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5514-5747","authenticated-orcid":false,"given":"J.N.","family":"Wagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Akelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7943-0860","authenticated-orcid":false,"given":"A.","family":"Ombeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6841-3384","authenticated-orcid":false,"given":"E.","family":"Okeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Onyango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3702-3030","authenticated-orcid":false,"given":"R.","family":"Omore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Khagayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3344-7226","authenticated-orcid":false,"given":"J.","family":"Were","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4825-0426","authenticated-orcid":false,"given":"HL.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.A.","family":"Tippett Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.vaccine.2023.07.063_b0005","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa0708630","article-title":"Effectiveness of maternal influenza immunization in mothers and infants","volume":"359","author":"Zaman","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2023.07.063_b0010","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/cid\/ciu327","article-title":"Maternal immunization","volume":"59","author":"Chu","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.063_b0015","doi-asserted-by":"crossref","first-page":"i102","DOI":"10.1093\/ije\/dyq027","article-title":"Tetanus toxoid immunization to reduce mortality from neonatal tetanus","volume":"39 Suppl 1(Suppl 1)","author":"Blencowe","year":"2010","journal-title":"Int J Epidemiol"},{"issue":"52","key":"10.1016\/j.vaccine.2023.07.063_b0020","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.1016\/j.vaccine.2014.09.052","article-title":"Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines","volume":"32","author":"Keller-Stanislawski","year":"2014","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2023.07.063_b0025","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1586\/14760584.2014.944509","article-title":"Neonatal pertussis, cocooning and maternal immunization","volume":"13","author":"Swamy","year":"2014","journal-title":"Exp Rev Vacc"},{"issue":"6","key":"10.1016\/j.vaccine.2023.07.063_b0030","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ajog.2009.09.034","article-title":"Safety of influenza vaccination during pregnancy","volume":"201","author":"Tamma","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2023.07.063_b0035","doi-asserted-by":"crossref","unstructured":"Munoz FM, Weisman LE, Read JS, Siberry G, Kotloff K, Friedman J, et al. Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancy. Clin Infect Diseases : Off Publ Infect Diseases Soc Am 59 Suppl 7(Suppl 7): S415\u201327. <https:\/\/doi.org\/10.1093\/cid\/ciu727>.","DOI":"10.1093\/cid\/ciu727"},{"key":"10.1016\/j.vaccine.2023.07.063_b0040","doi-asserted-by":"crossref","unstructured":"Munoz Flor M, Englund Janet A. Vaccines in pregnancy, infectious disease clinics of North America 2001; 15(1): 253-71, ISSN 0891-5520, <https:\/\/doi.org\/10.1016\/S0891-5520(05)70278-6>. (https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0891552005702786).","DOI":"10.1016\/S0891-5520(05)70278-6"},{"issue":"2","key":"10.1016\/j.vaccine.2023.07.063_b0045","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.2196\/medinform.8403","article-title":"Implementing an open source electronic health record system in kenyan health care facilities: case study","volume":"6","author":"Muinga","year":"2018","journal-title":"JMIR Med Inform"},{"key":"10.1016\/j.vaccine.2023.07.063_b0050","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3389\/fimmu.2020.01282","article-title":"Global perspectives on immunization during pregnancy and priorities for future research and development: an international consensus statement","volume":"11","author":"Abu-Raya","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.07.063_b0055","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/AOG.0000000000000581","article-title":"Vaccinations for pregnant women","volume":"125","author":"Swamy","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2023.07.063_b0060","article-title":"The importance of pharmacovigilance","author":"World Health Organization","year":"2002","journal-title":"World Health Organization"},{"key":"10.1016\/j.vaccine.2023.07.063_b0065","unstructured":"Kugo Chepkemboi Linet: The Vaccine Pharmacovigilance System Of Kenya; 2016. <http:\/\/erepository.uonbi.ac.ke\/bitstream\/handle\/11295\/97675\/Kugo_The%20Vaccine%20Pharmacovigilance%20System%20Of%20Kenya.pdf?sequence=5&isAllowed=y>."},{"key":"10.1016\/j.vaccine.2023.07.063_b0070","doi-asserted-by":"crossref","unstructured":"Kiguba R, Olsson S, Waitt C. Pharmacovigilance in low- and middle-income countries: a review with particular focus on Africa. Brit J Clin Pharmacol; 2021. 10.1111\/bcp.15193. <https:\/\/doi.org\/10.1111\/bcp.15193>.","DOI":"10.22541\/au.163256723.39408938\/v1"},{"key":"10.1016\/j.vaccine.2023.07.063_b0075","unstructured":"WHO. Brighton Collaboration. WHO Meeting to develop Brighton Collaboration definitions of key terms used for monitoring the safety of immunization in pregnancy in mothers and newborn children; 2014. p. 24\u20135. <https:\/\/www.who.int\/immunization\/research\/meetings_workshops\/brighton_keyterms_safety_pregnancy.pdf>."},{"key":"10.1016\/j.vaccine.2023.07.063_b0080","doi-asserted-by":"crossref","unstructured":"Kochhar S, Bauwens J, Bonhoeffer J, GAIA Project Participants. Electronic address: http:\/\/www.gaia-consortium.net\/. Safety assessment of immunization in pregnancy. Vaccine 2017; 35(48 Pt A): 6469\u201371. <https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.033>.","DOI":"10.1016\/j.vaccine.2017.09.033"},{"key":"10.1016\/j.vaccine.2023.07.063_b0085","unstructured":"Bauwens J, Bonhoeffer J, Chen RT. GAIA consortium: harmonising immunisation safety assessments in pregnancy. Vaccine (GAIA 2nd Special Issue); 2017."},{"key":"10.1016\/j.vaccine.2023.07.063_b0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12884-021-03686-9","article-title":"Maternal and neonatal data collection systems in low- and middle-income countries for maternal vaccines active safety surveillance systems: a scoping review","volume":"21","author":"Berrueta","year":"2021","journal-title":"BMC Pregn Childbirth"},{"key":"10.1016\/j.vaccine.2023.07.063_b0095","unstructured":"Kenya Integrated Data Warehouse available online at National Data Warehouse | Dashboard (nascop.org)."},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2023.07.063_b0100","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1093\/cid\/ciz609","article-title":"Health and demographic surveillance systems within the child health and mortality prevention surveillance network","volume":"69","author":"Cunningham","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2023.07.063_b0105","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/ije\/dys108","article-title":"Profile: the KEMRI\/CDC health and demographic surveillance system-western Kenya","volume":"41","author":"Odhiambo","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2023.07.063_b0110","unstructured":"Protection at birth (PAB) against neonatal tetanus and Tetanus toxoid-containing vaccine (TT2+\/Td2+) vaccination coverage. <https:\/\/immunizationdata.who.int\/pages\/coverage\/tt2plus.html>."},{"key":"10.1016\/j.vaccine.2023.07.063_b0115","doi-asserted-by":"crossref","unstructured":"Stuurman Anke L, Riera Margarita, Lamprianou Smaragda, Perez-Vilar Silvia, Anderson Steven A, Mangtani Punam, et al. Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: a feasibility assessment, Vaccine 2018; 36(45): 6736\u201343. ISSN 0264-410X, <https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.033>.","DOI":"10.1016\/j.vaccine.2018.09.033"},{"key":"10.1016\/j.vaccine.2023.07.063_b0120","doi-asserted-by":"crossref","unstructured":"Odhiambo Frank O, Laserson Kayla F, Sewe Maquins, Hamel Mary J, Feikin Daniel R, Adazu Kubaje, et al. Profile: the KEMRI\/CDC health and demographic surveillance system\u2014western Kenya, Int J Epidemiol 2012; 41(4): 977\u201387. <https:\/\/doi.org\/10.1093\/ije\/dys108>.","DOI":"10.1093\/ije\/dys108"},{"issue":"19","key":"10.1016\/j.vaccine.2023.07.063_b0125","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.vaccine.2021.03.016","article-title":"The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety","volume":"39","author":"Black","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.07.063_b0130","unstructured":"Open Health News. District Health Information System 2 (DHIS); 2011. <http:\/\/www.openhealthnews.com\/resources\/district-health-information-system-2-DHIS> [accessed 9 Jan 2022]."},{"key":"10.1016\/j.vaccine.2023.07.063_b0135","unstructured":"DHIS 2 in action https:\/\/DHIS.org\/in-action [accessed 9 Jan 2022]."},{"issue":"45","key":"10.1016\/j.vaccine.2023.07.063_b0140","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.1016\/j.vaccine.2018.09.033","article-title":"Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: a feasibility assessment","volume":"36","author":"Stuurman","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.07.063_b0145","unstructured":"Extract from GACVS meeting of 1-3 December 2020, published in the WHO Weekly Epidemiological Record of 22 January 2021."},{"key":"10.1016\/j.vaccine.2023.07.063_b0150","doi-asserted-by":"crossref","unstructured":"Watson G, Dodd C, Munoz FM, Eckert LO, Jones CE, Buttery JP et al. Applicability of the GAIA maternal and neonatal case definitions for the evaluation of adverse events following vaccination of pregnancy in high-income countries. Pedatr Inf Dis J. 2021 Dec 1;40(12):1127-1134. doi: 10:1097\/INF.000000000003261. PMID: 34596623.","DOI":"10.1097\/INF.0000000000003261"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23009064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23009064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T13:45:44Z","timestamp":1736343944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23009064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":30,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0264410X23009064"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.07.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine safety surveillance in Kenya using GAIA standards: A feasibility assessment of existing national and subnational research and program systems","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.07.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}